MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
term debt, net of...
$25,000K
Proceeds from exercise of
stock options
$658K
Net cash provided by
financing activities
$25,612K
Canceled cashflow
$46K
Net change in cash,
cash equivalents and...
-$693K
Canceled cashflow
$25,612K
Change in fair value of
the convertible...
$120,963K
Non-cash interest
expense
$16,568K
Impairment expense
$5,412K
Stock-based compensation
expense
$2,610K
Change in right-of-use
asset
-$2,364K
Depreciation expense
$1,531K
Prepaid expenses and
other assets
-$39K
Payments for taxes
related to net share...
$46K
Net cash used in
operating activities
-$25,763K
Canceled cashflow
$149,487K
Net cash used in
investing activities
-$542K
Net loss
-$173,799K
Operating lease liability
-$1,028K
Accounts payable and
accrued liabilities
-$334K
Accrued compensation
-$89K
Purchases of property and
equipment
$542K
Back
Back
Cash Flow
source: myfinsight.com
Armata Pharmaceuticals, Inc. (ARMP)
Armata Pharmaceuticals, Inc. (ARMP)